Revenue FY2025
—
Net Income
$(288.0M)
EPS (Basic)
$-3.08
Net Margin
—
ROE
544.7%
Total Equity
$(53.0M)
Shares Out
138M
COMPASS Pathways plc — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2019–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 5 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
ARK Investment Management
ARK Investment Management
$48.8M
0.3%
+4.6%
Royce & Associates
Royce & Associates
$3.8M
0.0%
(30.1%)
Renaissance Technologies
Renaissance Technologies
$20.3M
0.0%
+65.5%
Adage Capital Management
Adage Capital Management
$4.2M
0.0%
—
Alps Advisors
Alps Advisors
$1.9M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…